Silverfin false false 31/03/2026 01/04/2025 31/03/2026 S Mendoza 13/10/2017 15 October 2026 no description of principal activity 11011994 2026-03-31 11011994 bus:Director1 2026-03-31 11011994 2025-03-31 11011994 core:CurrentFinancialInstruments 2026-03-31 11011994 core:CurrentFinancialInstruments 2025-03-31 11011994 core:ShareCapital 2026-03-31 11011994 core:ShareCapital 2025-03-31 11011994 core:RetainedEarningsAccumulatedLosses 2026-03-31 11011994 core:RetainedEarningsAccumulatedLosses 2025-03-31 11011994 core:CostValuation 2025-03-31 11011994 core:AdditionsToInvestments 2026-03-31 11011994 core:DisposalsRepaymentsInvestments 2026-03-31 11011994 core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 11011994 core:CostValuation 2026-03-31 11011994 2024-03-31 11011994 2025-04-01 2026-03-31 11011994 bus:FilletedAccounts 2025-04-01 2026-03-31 11011994 bus:SmallEntities 2025-04-01 2026-03-31 11011994 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 11011994 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11011994 bus:Director1 2025-04-01 2026-03-31 11011994 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 11011994 (England and Wales)

DOZAFIC LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2026
Pages for filing with the registrar

DOZAFIC LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2026

Contents

DOZAFIC LIMITED

COMPANY INFORMATION

For the financial year ended 31 March 2026
DOZAFIC LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2026
DIRECTOR S Mendoza
REGISTERED OFFICE Level 1
Brockbourne House
77 Mount Ephraim
Tunbridge Wells
TN4 8BS
United Kingdom
COMPANY NUMBER 11011994 (England and Wales)
ACCOUNTANT S&W Partners Limited
14th Floor
103 Colmore Row
Birmingham
B3 3AG
DOZAFIC LIMITED

BALANCE SHEET

As at 31 March 2026
DOZAFIC LIMITED

BALANCE SHEET (continued)

As at 31 March 2026
Note 2026 2025
£ £
Fixed assets
Investments 3 4,947,683 4,573,129
4,947,683 4,573,129
Current assets
Cash at bank and in hand 48,741 2,062
48,741 2,062
Creditors: amounts falling due within one year 4 ( 3,521,679) ( 3,562,928)
Net current liabilities (3,472,938) (3,560,866)
Total assets less current liabilities 1,474,745 1,012,263
Provision for liabilities 5 ( 271,159) ( 193,509)
Net assets 1,203,586 818,754
Capital and reserves
Called-up share capital 122 122
Profit and loss account 1,203,464 818,632
Total shareholders' funds 1,203,586 818,754

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Dozafic Limited (registered number: 11011994) were approved and authorised for issue by the Director on 15 October 2026. They were signed on its behalf by:

S Mendoza
Director
DOZAFIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2026
DOZAFIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dozafic Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Level 1, Brockbourne House, 77 Mount Ephraim, Tunbridge Wells, TN4 8BS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The functional currency of Dozafic Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.

These financial statements are separate financial statements.

Going concern

The financial statements have been prepared on a going concern basis.

The director has made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise on monetary items.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on enacted or substantively enacted tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

Financial instruments

Financial assets and financial liabilities are recognised in the Balance Sheet when the Company becomes a party to the contractual provisions of the instrument.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

Trade and other debtors and creditors are classified as basic financial instruments and measured on initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the Company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank, short-term bank deposits with an original maturity of three months or less and bank overdrafts which are an integral part of the Company’s cash management.

Financial liabilities and equity instruments issued by the Company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Fixed asset investments

Listed investments Total
£ £
Cost or valuation before impairment
At 01 April 2025 4,573,129 4,573,129
Additions 662,721 662,721
Disposals ( 721,962) ( 721,962)
Movement in fair value 433,795 433,795
At 31 March 2026 4,947,683 4,947,683
Carrying value at 31 March 2026 4,947,683 4,947,683
Carrying value at 31 March 2025 4,573,129 4,573,129

4. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 6,426 6,120
Amounts owed to director 3,494,408 3,544,408
Accruals 11,801 12,400
Taxation and social security 9,044 0
3,521,679 3,562,928

5. Deferred tax

2026 2025
£ £
At the beginning of financial year ( 193,509) ( 144,143)
Charged to the Statement of Income and Retained Earnings ( 77,650) ( 49,366)
At the end of financial year ( 271,159) ( 193,509)

6. Related party transactions

Transactions with the entity's director

At the year end, the Company owed the director £3,494,408 (2025 - £3,544,408). This loan is unsecured, interest free and repayable on demand.